AU3096099A - Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof - Google Patents

Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof

Info

Publication number
AU3096099A
AU3096099A AU30960/99A AU3096099A AU3096099A AU 3096099 A AU3096099 A AU 3096099A AU 30960/99 A AU30960/99 A AU 30960/99A AU 3096099 A AU3096099 A AU 3096099A AU 3096099 A AU3096099 A AU 3096099A
Authority
AU
Australia
Prior art keywords
algs
immunomodulatory fragments
globulins
polyclonal antilymphocyte
polyclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30960/99A
Other languages
English (en)
Inventor
Nathalie Bonnefoy-Berard
Roland Buelow
Jean-Pierre Revillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangstat Medical Corp
Original Assignee
Sangstat Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangstat Medical Corp filed Critical Sangstat Medical Corp
Publication of AU3096099A publication Critical patent/AU3096099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU30960/99A 1998-03-18 1999-03-16 Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof Abandoned AU3096099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4071398A 1998-03-18 1998-03-18
US09040713 1998-03-18
PCT/US1999/005829 WO1999047166A1 (fr) 1998-03-18 1999-03-16 FRAGMENTS IMMUNOMODULATEURS DE GLOBULINES ANTILYMPHOCYTAIRES POLYCLONALES (ALGs) ET UTILISATIONS ASSOCIEES

Publications (1)

Publication Number Publication Date
AU3096099A true AU3096099A (en) 1999-10-11

Family

ID=21912517

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30960/99A Abandoned AU3096099A (en) 1998-03-18 1999-03-16 Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof

Country Status (2)

Country Link
AU (1) AU3096099A (fr)
WO (1) WO1999047166A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878852B1 (fr) * 2000-09-28 2007-02-23 Imtix Sangstat Procede de production d'immunoglobulines anti-thymocytes humains
CA2542840A1 (fr) * 2003-10-22 2005-05-12 University Of Rochester Antiserum anti-thymocyte et son utilisation pour declencher l'apoptose des cellules b
EP1877082A2 (fr) * 2004-06-18 2008-01-16 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Preparation des globulines anti-lymphocytic et anti-monocytic pour empecher des immuno-reactions
EP2029729A2 (fr) * 2006-05-31 2009-03-04 Genzyme Corporation Procédés d'utilisation de globuline anti-thymocyte et agents associés
US9486524B2 (en) * 2006-09-01 2016-11-08 Genticel Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells

Also Published As

Publication number Publication date
WO1999047166A1 (fr) 1999-09-23

Similar Documents

Publication Publication Date Title
AU3337297A (en) Fragments of leptin (ob protein)
AU4373696A (en) Antifungal treatment of nails
AU3785699A (en) Chip stack and method of making same
AU5036198A (en) Methods and devices for collection of soft tissue
AU2582195A (en) Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU3368395A (en) Surgical glove and suit
AU3096099A (en) Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof
AU3451397A (en) Modified protein g and fragments thereof
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
AU1812601A (en) Cover member and method of making same
AU6351896A (en) Elisa serodiagnosis of pig pleuropneumonia serotypes 5a and 5b
GB2339239B (en) Opening and closing apparatus of folding type
AU7819898A (en) Box-dependent myc-interacting protein (bin1) compositions and uses therefor
AU6280999A (en) Novel secreted immunomodulatory proteins and uses thereof
AU5131699A (en) Cryogranulation of activated protein c
AU5420099A (en) Method and aid for the early recognition of sunburn
EP1067964A4 (fr) Compositions immunomodulatoires d'antigenes mmtv et leurs techniques d'application
AU6037898A (en) Novel human atpase inhibitor protein
AU2657599A (en) Peptide mimotopes of carbohydrate antigens
SI1068241T1 (sl) Protitelesne variante in njihovi fragmenti
AU2003204475A1 (en) Fragments of leptin (ob protein)
AU2580299A (en) Synthesis of dysidiolide and uses thereof
AU2002366640A1 (en) Detection and removal of lead using lead-binding proteins
AU6744400A (en) Peptides consisting of fragments of gli-1 and sufuh and their use
AU4556899A (en) Prevention and treatment of sepsis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase